Dusseldorf - Delayed Quote EUR

Genscript Biotech Corp (G51.DU)

Compare
1.2600
0.0000
(0.00%)
At close: January 31 at 7:30:32 PM GMT+1
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,009,589.0000
839,529.0000
625,698.0000
490,096.0000
390,846.0000
Cost of Revenue
468,098.0000
429,976.0000
321,615.0000
207,578.0000
134,953.0000
Gross Profit
541,491.0000
409,553.0000
304,083.0000
282,518.0000
255,893.0000
Operating Expense
868,127.0000
808,623.0000
731,839.0000
651,730.0000
447,886.0000
Operating Income
-326,636.0000
-399,070.0000
-427,756.0000
-369,212.0000
-191,993.0000
Net Non Operating Interest Income Expense
61,776.0000
45,676.0000
-51.0000
407.0000
-1,134.0000
Pretax Income
-311,914.0000
-350,979.0000
-431,690.0000
-517,363.0000
-281,900.0000
Tax Provision
13,081.0000
4,142.0000
-3,719.0000
964.0000
-477.0000
Net Income Common Stockholders
-177,011.0000
-95,477.0000
-226,851.0000
-358,712.0000
-204,945.0000
Diluted NI Available to Com Stockholders
-177,011.0000
-95,477.0000
-226,851.0000
-358,712.0000
-204,945.0000
Total Expenses
1,336,225.0000
1,238,599.0000
1,053,454.0000
859,308.0000
582,839.0000
Net Income from Continuing & Discontinued Operation
-177,011.0000
-95,477.0000
-226,851.0000
-358,712.0000
-204,945.0000
Normalized Income
-108,607.2700
-118,738.5500
-232,938.1040
-259,141.4600
-211,074.6106
Interest Income
91,049.0000
73,186.0000
13,218.0000
2,785.0000
4,298.0000
Interest Expense
29,273.0000
27,510.0000
13,269.0000
2,378.0000
1,418.0000
Net Interest Income
61,776.0000
45,676.0000
-51.0000
407.0000
-1,134.0000
EBIT
-282,641.0000
-323,469.0000
-418,421.0000
-514,985.0000
-280,482.0000
EBITDA
-203,822.0000
-249,423.0000
-354,173.0000
-467,206.0000
-247,587.0000
Reconciled Cost of Revenue
468,098.0000
429,976.0000
321,615.0000
207,578.0000
134,953.0000
Reconciled Depreciation
78,819.0000
74,046.0000
64,248.0000
47,779.0000
32,895.0000
Net Income from Continuing Operation Net Minority Interest
-177,011.0000
-95,477.0000
-226,851.0000
-358,712.0000
-204,945.0000
Total Unusual Items Excluding Goodwill
-86,587.0000
29,445.0000
6,140.0000
-136,398.0000
6,140.0000
Total Unusual Items
-86,587.0000
29,445.0000
6,140.0000
-136,398.0000
6,140.0000
Normalized EBITDA
-117,235.0000
-278,868.0000
-360,313.0000
-330,808.0000
-253,727.0000
Tax Rate for Calcs
0.0002
0.0002
0.0000
0.0003
0.0000
Tax Effect of Unusual Items
-18,183.2700
6,183.4500
52.8960
-36,827.4600
10.3894
12/31/2020 - 1/9/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade